Brian Henick (@bhenickmd) 's Twitter Profile
Brian Henick

@bhenickmd

Proud husband/father. Phase I, Thoracic+Head/Neck Med Onc @ColumbiaCancer @NYPHospital @ColumbiaMed. Editor @JCOPO_ASCO. Views my own ≠ advice.

ID: 984249803818307584

calendar_today12-04-2018 02:00:14

165 Tweet

402 Followers

434 Following

Kristine Lacuna, MD (@kristinelacuna) 's Twitter Profile Photo

Thank you to my mentors and Herbert Irving Comprehensive Cancer Center Test Account @NCICTEP_ClinRes for pushing this #ETCTN trial forward for #sarcomas #rarediseases Huge thanks to Conquer Cancer, the ASCO Foundation for supporting our research. Excited to share more at #ASCO2024. Find me 6/1: 1:30-4:30PM Hall A Poster #452!

Herbert Irving Comprehensive Cancer Center (@columbiacancer) 's Twitter Profile Photo

Eight Columbia oncological physicians, scientists, and trainees have been awarded Conquer Cancer, the ASCO Foundation grants/awards to recognize and advance their impact on cancer research- Congratulations to these awardees, recognized at #ASCO24 !

Eight Columbia oncological physicians, scientists, and trainees have been awarded <a href="/ConquerCancerFd/">Conquer Cancer, the ASCO Foundation</a> grants/awards to recognize and advance their impact on cancer research- Congratulations to these awardees, recognized at #ASCO24 !
Fumiko Ladd Chino, MD, FASCO (@fumikochino) 's Twitter Profile Photo

🤩Excited to be selected for the 2024 ASCO Leadership Development Program. Overjoyed to join a group of motived oncologists for essential leadership skills training. The 2025 application is open soon. Completed training 2015-2020? You are eligible! society.asco.org/career-develop…

🤩Excited to be selected for the 2024 <a href="/ASCO/">ASCO</a> Leadership Development Program. Overjoyed to join a group of motived oncologists for essential leadership skills training.

The 2025 application is open soon. Completed training 2015-2020? You are eligible!
society.asco.org/career-develop…
JCO Precision Oncology (@jcopo_asco) 's Twitter Profile Photo

#JCOPO Editorial Fellows share insights into publication trends and future directions for JCO Precision Oncology ➡️ brnw.ch/21wKKen

#JCOPO Editorial Fellows share insights into publication trends and future directions for JCO Precision Oncology ➡️ brnw.ch/21wKKen
Herbert Irving Comprehensive Cancer Center (@columbiacancer) 's Twitter Profile Photo

Congratulations to the 2024 Precision Medicine Joint Pilot awardees! HICCC's research team, led by Carla Concepcion Crisol (PI) and Benjamin Herzberg will focus on evaluating SMARCA4-mutant non-small cell lung cancer.

Congratulations to the 2024 Precision Medicine Joint Pilot awardees! HICCC's research team, led by <a href="/cp_concepcion/">Carla Concepcion Crisol</a> (PI) and <a href="/bherzbergmd/">Benjamin Herzberg</a> will focus on evaluating SMARCA4-mutant non-small cell lung cancer.
AACR (@aacr) 's Twitter Profile Photo

AACR Project GENIE® held its Summer Summit this week in Philadelphia. Chaired by Brian Henick and Marilyn Li, the summit celebrated the 10th anniversary of the think tank convened by AACR Past-President @CharlesSawyers that launched this vital initiative. #AACRGENIE Brian Henick

AACR Project GENIE® held its Summer Summit this week in Philadelphia. Chaired by Brian Henick and Marilyn Li, the summit celebrated the 10th anniversary of the think tank convened by AACR Past-President @CharlesSawyers that launched this vital initiative.
#AACRGENIE <a href="/BHenickMD/">Brian Henick</a>
SWOG Cancer Research Network (@swog) 's Twitter Profile Photo

A Closer Look at the Innovative Pragmatica-Lung Trial SWOG Cancer Research Network S2302 chair Karen Reckamp, MD, MS interviewed on streamlined phase 3 trial in #NSCLC w broader eligibility & lower site burden. Rewriting how we do oncology #ClinicalTrials. Lung-MAP @NCICTEP_ClinRes medpagetoday.com/meetingcoverag…

Lung-MAP (@lungmap) 's Twitter Profile Photo

The Lung-MAP master protocol has screened more than 5,000 patients with advanced #NSCLC. Data from these patients are driving #research to further our understanding of common #lungcancer mutations and to discover future treatment targets. Learn more: lung-map.org

IASLC (@iaslc) 's Twitter Profile Photo

The #WCLC24 Highlights of the Day - Monday Abstracts is starting now. W/Brian Henick, Lauren Averett Byers, MD, #IASLC President Paul van Schil & Joachim Aerts. #LCSM #IASLC50 #LungCancer

The #WCLC24 Highlights of the Day - Monday Abstracts is starting now. W/<a href="/BHenickMD/">Brian Henick</a>, <a href="/LaurenByersMD/">Lauren Averett Byers, MD</a>, #IASLC President Paul van Schil &amp; Joachim Aerts. #LCSM #IASLC50 #LungCancer
Shilpa Gupta (@shilpaonc) 's Twitter Profile Photo

What a great LDP meeting ASCO HQ Deep dive into leadership styles, DiSC assessment, our team projects & a great finish by Sumanta K. Pal, MD, FASCO urging us to think of our 10yr goals, the why & how to get there! Grateful to be a part of this amazing community! I.DagogoJackMD Brian Henick

What a great LDP meeting <a href="/ASCO/">ASCO</a> HQ Deep dive into leadership styles, DiSC assessment, our team projects &amp; a great finish by <a href="/montypal/">Sumanta K. Pal, MD, FASCO</a> urging us to think of our 10yr goals, the why &amp; how to get there! 
Grateful to be a part of this amazing community! <a href="/IbiayiMD/">I.DagogoJackMD</a> <a href="/BHenickMD/">Brian Henick</a>
Brian Henick (@bhenickmd) 's Twitter Profile Photo

On behalf of our Phase I program Herbert Irving Comprehensive Cancer Center , proud of Benjamin Herzberg presenting exciting initial data on IDE397 in MTAP-del tumors at the EORTC - National Cancer Institute - AACR conference ir.ideayabio.com/2024-10-25-IDE… We are excited to offer this study to our patients recruit.cumc.columbia.edu/studyinfopage/…

Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile Photo

New #JITC article: Osteoarthritis increases the risk of inflammatory arthritis due to immune checkpoint inhibitors associated with tissue-resident memory T cells bit.ly/4iBsqfZ Brian Henick @ColumbiaCancer

New #JITC article: Osteoarthritis increases the risk of inflammatory arthritis due to immune checkpoint inhibitors associated with tissue-resident memory T cells bit.ly/4iBsqfZ <a href="/BHenickMD/">Brian Henick</a> @ColumbiaCancer